CAWM
Capital Advisors Wealth Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.9K | Hold |
42,555
| – | – | 0.01% | 189 |
|
|
2025
Q1 | $61.3K | Buy |
42,555
+7,500
| +21% | +$10.8K | 0.01% | 180 |
|
|
2024
Q4 | $77.1K | Buy |
35,055
+3,255
| +10% | +$7.16K | 0.01% | 173 |
|
|
2024
Q3 | $52.5K | Buy |
31,800
+5,000
| +19% | +$8.25K | 0.01% | 167 |
|
|
2024
Q2 | $59.5K | Buy |
26,800
+5,000
| +23% | +$11.1K | 0.01% | 159 |
|
|
2024
Q1 | $58.4K | Buy |
+21,800
| New | +$58.4K | 0.01% | 156 |
|